Randomized Controlled Trials for the Treatment of Hidradenitis Suppurativa
| Autor: | Dominique C. van Rappard, Jan R. Mekkes, Thrasivoulos Tzellos |
|---|---|
| Přispěvatelé: | AII - Amsterdam institute for Infection and Immunity, APH - Amsterdam Public Health, Dermatology |
| Rok vydání: | 2015 |
| Předmět: |
Ethinyl Estradiol-Norgestrel Combination
medicine.medical_specialty Evidence-based practice Dermatologic Surgical Procedures Alternative medicine Dermatology Disease law.invention 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Randomized controlled trial law Outcome Assessment Health Care Medicine Humans Hidradenitis suppurativa 030212 general & internal medicine Low-Level Light Therapy Intensive care medicine Randomized Controlled Trials as Topic business.industry Intense Pulsed Light Therapy medicine.disease Hormones Infliximab Anti-Bacterial Agents Hidradenitis Suppurativa Clinical Practice Relative risk Physical therapy Dermatologic Agents Laser Therapy business Systematic search |
| Zdroj: | Dermatologic clinics, 34(1), 69-80. W.B. Saunders Ltd |
| ISSN: | 1558-0520 0733-8635 |
| Popis: | Hidradenitis suppurativa (HS) is a chronic, inflammatory, recurrent, debilitating skin disease. Several treatment modalities are available, but most of them lack high-quality evidence. A systematic search was performed to identify all randomized controlled trials for the treatment of HS in order to review and evaluate the evidence. Recommendations for future randomized controlled trials include using validated scores, inclusion of patient rated outcomes, and thorough report of side effects. Evidence for long-term treatment and benefit/risk ratio of available treatment modalities is needed in order to enhance evidence-based treatment in daily clinical practice. Combining surgery with antiinflammatory treatment warrants further investigation. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|